Skip to main content
Year archive

Galapagos NV — 2025 filings

All 162 regulatory filings released by Galapagos NV (GLPG) in 2025, sourced directly from the official regulator.

162 Filings
2025 Period
2025 filings (162)
Filing Released Lang
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus
Earnings Release Q4 2025
2025-12-19 Dutch
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus
Regulatory Filings
2025-12-19 English
TYK2 2025 EN.pdf
Earnings Release Q4 2025
2025-12-18 English
TYK2 2025 NL.pdf
Regulatory Filings
2025-12-18 Dutch
6-K Filing
Foreign Filer Report
2025-12-18 English
S-8 Filing
Registration Form
2025-12-10 English
Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025
Regulatory Filings
2025-12-08 Dutch
Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025
Regulatory Filings
2025-12-08 English
6-K Filing
Foreign Filer Report
2025-12-08 English
Galapagos Receives Transparency Notifications from Bank of America
Major Shareholding Notification
2025-11-26 Dutch
Galapagos Receives Transparency Notifications from Bank of America
Major Shareholding Notification
2025-11-26 English
Galapagos Receives Transparency Notifications from Bank of America
Major Shareholding Notification
2025-11-26 English
Galapagos Receives Transparency Notifications from Bank of America
Major Shareholding Notification
2025-11-26 English
GALAPAGOS_NV_Corp_Structure_TD_14.11.2025.pdf
Investor Presentation
2025-11-26 German
GALAPAGOS_NV_Corp_Structure_TD_12.11.2025.pdf
Investor Presentation
2025-11-26 German
GALAPAGOS NV Form TD 14.11.2025_Revised Part I.pdf
Major Shareholding Notification
2025-11-26 English
GALAPAGOS NV Form TD 12.11.2025_Part I_Revision2.pdf
Major Shareholding Notification
2025-11-26 English
Galapagos Receives Transparency Notifications from Bank of America .pdf
Major Shareholding Notification
2025-11-26 English
Galapagos ontvangt transparantieverklaringen van Bank of America .pdf
Major Shareholding Notification
2025-11-26 Dutch
6-K Filing
Foreign Filer Report
2025-11-26 English
Galapagos Reports Nine Months 2025 Financial Results and Provides Business Update
Interim / Quarterly Report 9M 2025
2025-11-06 English
Galapagos Reports Nine Months 2025 Financial Results and Provides Business Update
Interim / Quarterly Report 9M 2025
2025-11-06 Dutch
6-K Filing
Foreign Filer Report
2025-11-06 English
Galapagos Reports Nine Months 2025 Financial Results and Provides Business Update .pdf
Interim / Quarterly Report 9M 2025
2025-11-05 English
Galapagos rapporteert financiële resultaten over de eerste negen maanden van 2025 en geeft bedrijfsupdate.pdf
Interim / Quarterly Report 9M 2025
2025-11-05 Dutch
Galapagos to Present New Data from Cell Therapy Program at ASH 2025
Regulatory Filings
2025-11-04 Dutch
Galapagos to Present New Data from Cell Therapy Program at ASH 2025
Regulatory Filings
2025-11-04 English
6-K Filing
Foreign Filer Report
2025-11-03 English
Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Business Development
Board/Management Information
2025-10-31 Dutch
Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Business Development
Board/Management Information
2025-10-31 English
6-K Filing
Foreign Filer Report
2025-10-30 English
SCHEDULE 13G Filing
Major Shareholding Notification
2025-10-29 English
Galapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Differentiation of GLPG3667 from Other TYK2 Inhibitors
Regulatory Filings
2025-10-24 English
Galapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Differentiation of GLPG3667 from Other TYK2 Inhibitors
Regulatory Filings
2025-10-24 Dutch
6-K Filing
Foreign Filer Report
2025-10-24 English
Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation
Regulatory Filings
2025-10-21 Dutch
Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation
Capital/Financing Update
2025-10-21 English
Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation.pdf
Regulatory Filings
2025-10-21 English
Galapagos kondigt intentie aan om celtherapieactiviteiten af te bouwen als onderdeel van de voortdurende transformatie van het bedrijf.pdf
Regulatory Filings
2025-10-21 Dutch
6-K Filing
Foreign Filer Report
2025-10-21 English
Galapagos Announces Appointment of Fred Blakeslee as General Counsel
Board/Management Information
2025-10-17 Dutch
Galapagos Announces Appointment of Fred Blakeslee as General Counsel
Board/Management Information
2025-10-17 English
6-K Filing
Foreign Filer Report
2025-10-16 English
Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business
M&A Activity
2025-10-02 English
Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business
M&A Activity
2025-10-02 Dutch
6-K Filing
Foreign Filer Report
2025-10-01 English
Galapagos Creates New Subscription Right Plan
Share Issue/Capital Change
2025-08-08 Dutch
Galapagos Creates New Subscription Right Plan
Share Issue/Capital Change
2025-08-08 English
6-K Filing
Foreign Filer Report
2025-08-07 English
Galapagos_PR_07082025_ENG.pdf
Remuneration Information
2025-08-07 English
Galapagos_PR_07082025_NL.pdf
Remuneration Information
2025-08-07 Dutch
1. Subscription Right Plan 2025 (B)_Board Report_7_180-7_191_ENG_FINAL_Website(inclplan)(2039027.1).pdf
Report Publication Announcement
2025-08-07 English
1. Subscription Right Plan 2025 (B)_Board Report_7_180-7_191_NL_FINAL_Website(inclplan)(2039028.1).pdf
Management Reports
2025-08-07 Dutch
Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
Regulatory Filings
2025-08-06 Dutch
Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
Regulatory Filings
2025-08-06 English
Galapagos Press Release_RMAT Designation_GLPG5101_ENG_final.pdf
Regulatory Filings
2025-08-06 English
Galapagos Press Release_RMAT Designation_GLPG5101_NLfinal.pdf
Regulatory Filings
2025-08-06 Dutch
6-K Filing
Foreign Filer Report
2025-08-06 English
SCHEDULE 13D/A Filing
Major Shareholding Notification
2025-07-28 English
Galapagos Bolster Leadership Team with Seasoned Life Sciences Executives to Accelerate Business Transformation
Board/Management Information
2025-07-24 Dutch
Galapagos Bolster Leadership Team with Seasoned Life Sciences Executives to Accelerate Business Transformation
Board/Management Information
2025-07-24 English
Galapagos Welcomes Seasoned Pharmaceutical Executives Dawn Svoronos and Jane Griffiths to Its Board of Directors
Board/Management Information
2025-07-24 English
Galapagos verwelkomt ervaren farmaceutische leidinggevenden Dawn Svoronos en Jane Griffiths in haar Raad van Bestuur
Board/Management Information
2025-07-24 Dutch
Galapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter Business Update
Interim / Quarterly Report H1 2025
2025-07-24 English
Galapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter Business Update
Earnings Release H1 2025
2025-07-24 Dutch
6-K Filing
Foreign Filer Report
2025-07-24 English
6-K Filing
Foreign Filer Report
2025-07-24 English
Galapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter Business Update.pdf
Earnings Release H1 2025
2025-07-23 English
Galapagos rapporteert halfjaarcijfers 2025 en geeft een update over de activiteiten in het tweede kwartaal.pdf
Earnings Release H1 2025
2025-07-23 Dutch
Galapagos Half-Year report 2025.pdf
Interim / Quarterly Report H1 2025
2025-07-23 English
Galapagos Halfjaarverslag 2025.pdf
Interim / Quarterly Report H1 2025
2025-07-23 Dutch
6-K Filing
Foreign Filer Report
2025-07-23 English
6-K Filing
Foreign Filer Report
2025-06-25 English
Galapagos benoemt Aaron Cox als Chief Financial Officer
Board/Management Information
2025-06-23 Dutch
Galapagos benoemt Aaron Cox als Chief Financial Officer
Board/Management Information
2025-06-23 English
Galapagos Press Release_CFO_ENG.pdf
Board/Management Information
2025-06-23 English
Galapagos Press Release_CFO_NL.pdf
Board/Management Information
2025-06-23 Dutch
6-K Filing
Foreign Filer Report
2025-06-20 English
Company announcement
Earnings Release Q4 2024
2025-06-19 Dutch
Company announcement
Earnings Release Q4 2024
2025-06-19 English
Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL
Regulatory Filings
2025-06-13 Dutch
Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL
Regulatory Filings
2025-06-13 English
6-K Filing
Foreign Filer Report
2025-06-13 English
Galapagos Creates New Subscription Right Plan
Share Issue/Capital Change
2025-05-28 Dutch
Galapagos Creates New Subscription Right Plan
Capital/Financing Update
2025-05-28 English
6-K Filing
Foreign Filer Report
2025-05-28 English
Subscription-Right-Plan-2025-A-Board-Report_English_Final_Website.pdf
Share Issue/Capital Change
2025-05-27 English
Subscription-Right-Plan-2025-A-Board-Report_Dutch_Final_Website.pdf
Capital/Financing Update
2025-05-27 Dutch
SCHEDULE 13D/A Filing
Major Shareholding Notification
2025-05-19 English
Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational CAR-T Candidate GLPG5101
Regulatory Filings
2025-05-15 English
Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational CAR-T Candidate GLPG5101
Regulatory Filings
2025-05-15 English
6-K Filing
Foreign Filer Report
2025-05-14 English
Galapagos kondigt een strategische update aan over de geplande splitsing, de transitie van het uitvoerend leiderschap, en wijzigingen in de Raad van Bestuur
Board/Management Information
2025-05-13 English
Galapagos kondigt een strategische update aan over de geplande splitsing, de transitie van het uitvoerend leiderschap, en wijzigingen in de Raad van Bestuur
Board/Management Information
2025-05-13 English
GLPG Press-release Strategic Review May 2025 ENG.pdf
Board/Management Information
2025-05-13 English
GLPG Press Release Strategic Review May 2025_NL.pdf
Board/Management Information
2025-05-13 Dutch
6-K Filing
Foreign Filer Report
2025-05-13 English
2025-AGM-Minutes_ENG-version_29042025_website2030440.1.pdf
AGM Information
2025-04-30 English
2025-AGM-Minutes_NL-version_29042025_website2030407.2.pdf
AGM Information
2025-04-30 Dutch
6-K Filing
Foreign Filer Report
2025-04-29 English
Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts
Interim / Quarterly Report Q1 2025
2025-04-24 English
Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts
Interim / Quarterly Report Q1 2025
2025-04-24 Dutch
Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts
Earnings Release Q1 2025
2025-04-24 Dutch
Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts .pdf
Interim / Quarterly Report Q1 2025
2025-04-23 English
Galapagos rapporteert resultaten over het eerste kwartaal van 2025, recente hoogtepunten en verwachtingen op korte termijn .pdf
Interim / Quarterly Report Q1 2025
2025-04-23 Dutch
6-K Filing
Foreign Filer Report
2025-04-23 English
Galapagos Announces Executive Leadership Updates
Board/Management Information
2025-04-22 Dutch
Galapagos Announces Executive Leadership Updates
Board/Management Information
2025-04-22 English
Galapagos Announces Executive Leadership Updates
Board/Management Information
2025-04-22 English
GLPG NV_ENG_glpg-press-release-executive-leadership-updates-250421-eng.pdf
Board/Management Information
2025-04-21 English
GLPG NV_NL-glpg-press-release-executive-leadership-updates-250421.pdf
Board/Management Information
2025-04-21 Dutch
6-K Filing
Foreign Filer Report
2025-04-21 English
Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025
Board/Management Information
2025-04-15 Dutch
Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025
Board/Management Information
2025-04-15 English
Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025
Board/Management Information
2025-04-15 English
Galapagos_Press release_FINAL_15042025_ENG(2029218.1).pdf
Board/Management Information
2025-04-15 English
GLPG Press Release_Final_15042025_NL(2029217.1).pdf
Board/Management Information
2025-04-15 Dutch
Press release Galapagos_15042025.pdf
Board/Management Information
2025-04-15 English
Persbericht_Galapagos_15042025.pdf
Board/Management Information
2025-04-15 Dutch
6-K Filing
Foreign Filer Report
2025-04-15 English
Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders’ Meeting
Report Publication Announcement
2025-03-28 English
Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders’ Meeting
Report Publication Announcement
2025-03-28 Dutch
Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders’ Meeting
AGM Information
2025-03-28 Dutch
6-K Filing
Foreign Filer Report
2025-03-28 English
Galapagos Annual Report 2024.pdf
Annual Report FY 2024
2025-03-27 English
Galapagos-NV_statutory-accounts_Fy-2024_EN_20.03.205.pdf
Annual Report FY 2024
2025-03-27 English
Documents AGM_EN.pdf
Proxy Solicitation & Information Statement
2025-03-27 English
Documents AGM_NL.pdf
Proxy Solicitation & Information Statement
2025-03-27 Dutch
Galapagos Jaarverslag 2024.pdf
Annual Report FY 2024
2025-03-27 Dutch
Galapagos-NV_statutory-accounts_Fy-2024_NL_20.03.2025.pdf
Annual Report FY 2024
2025-03-27 Dutch
GLPG -- Convening Notice (ENG)_FINAL.pdf
Proxy Solicitation & Information Statement
2025-03-27 English
GLPG -- Convening Notice - final (NL)_FINAL.pdf
Proxy Solicitation & Information Statement
2025-03-27 Dutch
Galapagos Annual Report 2024.pdf
Annual Report FY 2024
2025-03-27 English
Galapagos Jaarverslag 2024.pdf
Annual Report FY 2024
2025-03-27 Dutch
699400FG6E2AD50YHF38-2024-12-31-0-nl.xhtml
Annual Report FY 2024
2025-03-27 Dutch
699400FG6E2AD50YHF38-2024-12-31-0-nl (1).zip
Annual Report (ESEF) FY 2024
2025-03-27 Dutch
20-F Filing
Annual Report FY 2024
2025-03-27 English
6-K Filing
Foreign Filer Report
2025-02-24 English
6-K Filing
Foreign Filer Report
2025-02-18 English
Transparency Notification 2.14.25 redacted.pdf
Major Shareholding Notification
2025-02-17 English
Galapagos receives transparency notification and 13D filing from Tang Capital .pdf
Major Shareholding Notification
2025-02-17 English
Galapagos ontvangt transparantieverklaring en 13D-filing van Tang Capital .pdf
Major Shareholding Notification
2025-02-17 Dutch
SCHEDULE 13D Filing
Major Shareholding Notification
2025-02-14 English
Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update
Earnings Release FY 2024
2025-02-13 English
Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update
Annual Report FY 2024
2025-02-13 English
Galapagos rapporteert resultaten over het gehele jaar 2024 en geeft een business update over het vierde kwartaal
Earnings Release FY 2024
2025-02-13 Dutch
Galapagos rapporteert resultaten over het gehele jaar 2024 en geeft een business update over het vierde kwartaal
Annual Report FY 2024
2025-02-13 Dutch
Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update.pdf
Earnings Release FY 2024
2025-02-12 English
Galapagos rapporteert resultaten over het gehele jaar 2024 en geeft een business update over het vierde kwartaal.pdf
Earnings Release FY 2024
2025-02-12 Dutch
Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update.pdf
Earnings Release FY 2024
2025-02-12 English
Galapagos rapporteert resultaten over het gehele jaar 2024 en geeft een business update over het vierde kwartaal.pdf
Earnings Release FY 2024
2025-02-12 Dutch
6-K Filing
Foreign Filer Report
2025-02-12 English
Galapagos presenteert op de 43ste jaarlijkse J.P. Morgan Healthcare Conference
Investor Presentation
2025-01-08 English
Galapagos presenteert op de 43ste jaarlijkse J.P. Morgan Healthcare Conference
Investor Presentation
2025-01-08 Dutch
Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities
Regulatory Filings
2025-01-08 Dutch
Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities
M&A Activity
2025-01-08 English
GLPG press release_ENG_FINAL CLEAN.pdf
M&A Activity
2025-01-08 English
GLPG press release_NL_FINAL CLEAN.pdf
M&A Activity
2025-01-08 Dutch
GLPG press release_ENG_FINAL CLEAN.pdf
M&A Activity
2025-01-08 English
GLPG press release_NL_FINAL CLEAN.pdf
Delisting Announcement
2025-01-08 Dutch
6-K Filing
Foreign Filer Report
2025-01-08 English
6-K Filing
Foreign Filer Report
2025-01-08 English